Arcutis director Robert A. Scott receives stock options

Q: How many stock options did ARQT director Robert A. Scott receive?

On October 23, 2026, Robert A. Scott received 20,507 options and 8,663 options, each with a $31.20 exercise price and an October 23, 2036 expiration date. The 20,507-option award vests in thirds annually beginning October 23, 2027, reaching full vesting on the third anniversary. The 8,663-option award vests in full on the earlier of June 5, 2027, or immediately before the next annual meeting; both awards are subject to continued service.

Q: What are the vesting terms for Robert A. Scott’s ARQT RSUs?

Scott received 2,819 RSUs, with each RSU entitling him to one common share upon vesting. They vest on the earlier of June 5, 2027, or immediately before the next annual meeting, subject to his continued service through the vesting date.

The 2,819 restricted stock units vest on the earlier of June 5, 2027, or immediately before the next annual meeting, subject to continued service.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Arcutis Biotherapeutics, Inc. director Robert A. Scott received two stock-option awards on October 23, 2026: 20,507 options and 8,663 options, each with a $31.20 exercise price and an expiration date of October 23, 2036. The first award vests in thirds annually beginning October 23, 2027; the second vests in full on the earlier of June 5, 2027, or immediately before the next annual meeting. Scott also received an award identified as restricted stock units (RSUs); the common-stock entry reports 2,819 shares following the transaction. Vesting is subject to continued service.

Insider Trade Summary

Grant/Award: 31,989 shares

Grant/Award 3 txns

Insider SCOTT ROBERT A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) ^F2	20,507	$0.00	$0.00
Grant/Award	Stock Option (right to buy) ^F3	8,663	$0.00	$0.00
Grant/Award	Common Stock ^F1	2,819	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 29,170 contracts (Direct); Common Stock — 2,819 shares (Direct)

Footnotes (3)

F1. Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.
F2. 1/3 each of the underlying shares subject to the option vest and become exercisable on the first annual anniversary of October 23, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the non-employee director's continued service through each applicable vesting date.
F3. The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.

Key Figures

Stock-option award: 20,507 options Stock-option award: 8,663 options Exercise price: $31.20 per share +2 more

5 metrics

Stock-option award 20,507 options Granted October 23, 2026

Stock-option award 8,663 options Granted October 23, 2026

Exercise price $31.20 per share Applies to both option awards

Restricted stock units 2,819 RSUs Granted October 23, 2026

Option expiration date October 23, 2036 Applies to both option awards

Key Terms

restricted stock units, Vesting Commencement Date, exercisable

3 terms

restricted stock units financial

"Represents restricted stock units ("RSUs") granted in connection"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Vesting Commencement Date financial

"the "Vesting Commencement Date""

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

exercisable financial

"fully vested and exercisable on the third anniversary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did ARQT director Robert A. Scott receive?

On October 23, 2026, Robert A. Scott received 20,507 options and 8,663 options, each with a $31.20 exercise price and an October 23, 2036 expiration date. The 20,507-option award vests in thirds annually beginning October 23, 2027, reaching full vesting on the third anniversary. The 8,663-option award vests in full on the earlier of June 5, 2027, or immediately before the next annual meeting; both awards are subject to continued service.

What are the vesting terms for Robert A. Scott’s ARQT RSUs?

Scott received 2,819 RSUs, with each RSU entitling him to one common share upon vesting. They vest on the earlier of June 5, 2027, or immediately before the next annual meeting, subject to his continued service through the vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/28/2026 - 04:20 PM EDT Accepted by SEC EDGAR 10/28/2026 - 04:20 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCOTT ROBERT A

(Last)

(First)

(Middle)

C/O ARCUTIS BIOTHERAPEUTICS, INC.

3027 TOWNSGATE ROAD, SUITE 300

(Street)

WESTLAKE VILLAGE

CALIFORNIA

91361

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arcutis Biotherapeutics, Inc. [ ARQT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/23/2026		A		2,819⁽¹⁾	A	$0	2,819	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$31.2	10/23/2026		A		20,507		⁽²⁾	10/23/2036	Common Stock	20,507	$0	20,507	D
Stock Option (right to buy)	$31.2	10/23/2026		A		8,663		⁽³⁾	10/23/2036	Common Stock	8,663	$0	8,663	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.

2. 1/3 each of the underlying shares subject to the option vest and become exercisable on the first annual anniversary of October 23, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the non-employee director's continued service through each applicable vesting date.

3. The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.

Remarks:

	/s/ Latha Vairavan, as Attorney-in-Fact for Robert A. Scott	10/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR